A detailed history of Exome Asset Management LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 225,323 shares of ETNB stock, worth $2.38 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
225,323
Previous 300,600 25.04%
Holding current value
$2.38 Million
Previous $2.22 Billion 20.79%
% of portfolio
1.32%
Previous 1.5%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$7.03 - $10.05 $529,197 - $756,533
-75,277 Reduced 25.04%
225,323 $1.76 Billion
Q3 2024

Nov 14, 2024

BUY
$7.36 - $9.66 $2.21 Million - $2.9 Million
300,600 New
300,600 $2.22 Billion

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $491M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.